Moolec Science SA income statement MLEC

Annual Quarterly

In fiscal 2024, which ended Jun 30, 2024, Moolec Science SA reported revenue of $5.6 million, up 521.5% from the year before. It recorded a net loss of $7.3 million. The operating loss came to $9.0 million, an operating margin of -160.8%. Diluted earnings per share were -$0.19.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2024
Jun 30, 2024
FY 2023
Jun 30, 2023
Revenue
6
+521.5%
1
Cost of revenue
5
+391.5%
1
Gross profit
0
+429.8%
-0
Research and development
2
+31.2%
1
Selling, general and administrative
—
0
Operating income
-9
-35.9%
-7
Pretax income
-8
+83.9%
-52
Income tax
-1
-346.4%
-0
Net income
-7
+85.9%
-52
Basic EPS
-0.19
+87.3%
-1.50
Diluted EPS
-0.19
+87.3%
-1.50
Weighted average shares, diluted
38
+9.9%
34
Other measures
Depreciation and amortization
—
0
EBITDA
—
-7
Interest coverage
-219.94x
-41.58x
Margins
Gross margin
8.40%
-15.83%
Operating margin
-160.76%
-735.19%
Pretax margin
-148.61%
-5,748.13%
Profit margin
-129.99%
-5,722.22%
EBITDA margin
—
-732.60%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Food and Kindred Products (SIC 2000)
Listed as
MLEC (Nasdaq), MLECW (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Cayman Islands
Headquarters
Grand Cayman
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1937737

Other Food and Kindred Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.